BG
EPZM

BlackRock Group’s Epizyme, Inc EPZM Stock Holding History

BlackRock Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$179K Buy
14,777
+4,403
+42% +$46K ﹤0.01% 2693
2016
Q3 		$102K Buy
10,374
+371
+4% +$3.39K ﹤0.01% 2815
2016
Q2 		$103K Sell
10,003
-123
-1% -$1.37K ﹤0.01% 2786
2016
Q1 		$123K Buy
10,126
+5,339
+112% +$54K ﹤0.01% 2699
2015
Q4 		$77K Sell
4,787
-168
-3% -$2.49K ﹤0.01% 2751
2015
Q3 		$64K Buy
4,955
+1,109
+29% +$22.4K ﹤0.01% 2807
2015
Q2 		$92K Buy
3,846
+1,906
+98% +$36.7K ﹤0.01% 2772
2015
Q1 		$36K Buy
1,940
+1,530
+373% +$31.6K ﹤0.01% 2803
2014
Q4 		$8K Hold
410
– – ﹤0.01% 2859
2014
Q3 		$11K Buy
+410
New +$12.7K ﹤0.01% 2803
2013
Q4 		– Sell
-2,131
Closed -$85K – 2808
2013
Q3 		$85K Buy
+2,131
New +$72.2K ﹤0.01% 2632

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BlackRock Group's EPZM Position: Q4 2016 in Review

BlackRock Group increased its Epizyme, Inc (EPZM) stake by 42% in Q4 2016, buying an estimated $46K and bringing the position to 14,777 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

BlackRock Group first reported a position in EPZM in Q3 2013 and has held it in 11 quarters since. 94 funds tracked by Wall St. Rank hold EPZM as of Q4 2016.

  • BlackRock Group held 14,777 shares of Epizyme, Inc worth $179K as of Q4 2016.
  • BlackRock Group bought 4,403 Epizyme, Inc shares in Q4 2016, an estimated $46K.
  • Epizyme, Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2693 holding.
  • BlackRock Group first reported a position in Epizyme, Inc in Q3 2013 and has held it in 11 quarters since.
  • 94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.